Background Serum biomarkers may inform and improve care in traumatic brain injury (TBI).
We aimed to correlate serum biomarkers with clinical severity, care path and imaging …

The purpose of this study was to correlate the early levels of glial fibrillary acidic protein
(GFAP) and neurofilament light protein (NF-L) with outcome in patients with mild traumatic …

Plasma tau and glial fibrillary acidic protein (GFAP) are promising biomarkers for identifying
traumatic brain injury (TBI) patients with intracranial trauma on computed tomography (CT) …

BACKGROUND Recent studies have suggested that glial fibrillary acidic protein (GFAP)
serum concentrations distinguish between intracerebral hemorrhage (ICH) and ischemic …

Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) have
been studied as potential biomarkers of mild traumatic brain injury (mTBI). We report the …

Background: Biomarkers of stroke are an evolving field of clinical research. A serum marker
which can differentiate between haemorrhagic and ischaemic stroke in the very early phase …

Background and Purpose The brain-specific astroglial protein GFAP is a blood biomarker
candidate indicative of intracerebral hemorrhage in patients with symptoms suspicious of …

Glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1)
may aid in the evaluation of traumatic brain injury (TBI). The objective of this analysis was to …

Objective The objective was to determine the accuracy of a new, rapid blood test combining
measurements of both glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl‐terminal …

BACKGROUND Glial fibrillary acidic protein (GFAP) is a biomarker candidate indicative of
intracerebral hemorrhage (ICH) in patients with symptoms of acute stroke. GFAP is released …